Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,368 | -5,474 | -3,542 | -1,458 | -5,118 |
| Depreciation Amortization | -1,525 | -1,496 | -944 | -488 | 1,489 |
| Income taxes - deferred | N/A | N/A | -1,641 | N/A | N/A |
| Accounts receivable | 120 | 666 | 103 | 650 | -1,023 |
| Other Working Capital | 2,500 | 2,303 | 1,008 | 1,647 | 2,402 |
| Other Operating Activity | -1,308 | -2,167 | 336 | -1,396 | -1,879 |
| Operating Cash Flow | $-8,581 | $-6,168 | $-4,680 | $-1,045 | $-4,129 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -24 | -19 | -17 | 6 |
| Purchase Sale Intangibles | -609 | -490 | -490 | -490 | N/A |
| Other Investing Activity | -629 | -510 | -490 | -490 | 50 |
| Investing Cash Flow | $-658 | $-534 | $-509 | $-507 | $56 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54,287 | 34,200 | 54,241 | 54,187 | 23,500 |
| Other Financing Activity | -3,250 | 16,726 | -3,284 | -3,254 | -3,032 |
| Financing Cash Flow | $51,037 | $50,926 | $50,957 | $50,933 | $20,468 |
| Exchange Rate Effect | -769 | -493 | -171 | -281 | 38 |
| Beginning Cash Position | 24,271 | 24,271 | 24,271 | 24,271 | 7,838 |
| End Cash Position | 65,300 | 68,002 | 69,868 | 73,371 | 24,271 |
| Net Cash Flow | $41,029 | $43,731 | $45,597 | $49,100 | $16,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,581 | -6,168 | -4,680 | -1,045 | -4,129 |
| Capital Expenditure | -30 | -25 | -20 | -17 | N/A |
| Free Cash Flow | -8,611 | -6,193 | -4,700 | -1,062 | -4,129 |